Particle.news

Spanish Regions Launch 2026–27 Infant RSV Immunization Campaigns

Authorities expand access to nirsevimab to cut hospital admissions, streamline delivery, protect thousands of infants this season.

Overview

  • Regional health services have opened coordinated seasonal programs that deliver nirsevimab, a long‑acting monoclonal antibody given through public clinics rather than pharmacies.
  • Córdoba is offering primary‑care delivery with a new drop‑in 'acto único' for a defined birth cohort and will administer nirsevimab without a doctor’s prescription or signed informed consent to speed access.
  • Galicia is running hospital‑based immunizations with staged call‑ups through the end of the campaign period and reported high prior uptake of 13,075 infants vaccinated last season.
  • Authorities cite strong effectiveness and coverage from prior seasons, reporting roughly 80% fewer hospital admissions among immunized infants in Córdoba and declines above 90% in Galicia, with regional coverage rates above 95% in target groups.
  • Pediatricians urge parents to vaccinate and to watch for bronchiolitis warning signs such as extreme sleepiness, breathing difficulty, poor feeding or high fever because broader immunization should cut ICU admissions and ease pressure on paediatric wards.